Department of Public Health and Infectious Diseases, Section of Microbiology, University of Rome "Sapienza", Rome, Italy.
Front Cell Infect Microbiol. 2024 Apr 4;14:1377012. doi: 10.3389/fcimb.2024.1377012. eCollection 2024.
It is becoming increasingly clear that the human microbiota, also known as "the hidden organ", possesses a pivotal role in numerous processes involved in maintaining the physiological functions of the host, such as nutrient extraction, biosynthesis of bioactive molecules, interplay with the immune, endocrine, and nervous systems, as well as resistance to the colonization of potential invading pathogens. In the last decade, the development of metagenomic approaches based on the sequencing of the bacterial 16s rRNA gene via Next Generation Sequencing, followed by whole genome sequencing via third generation sequencing technologies, has been one of the great advances in molecular biology, allowing a better profiling of the human microbiota composition and, hence, a deeper understanding of the importance of microbiota in the etiopathogenesis of different pathologies. In this scenario, it is of the utmost importance to comprehensively characterize the human microbiota in relation to disease pathogenesis, in order to develop novel potential treatment or preventive strategies by manipulating the microbiota. Therefore, this perspective will focus on the progress, challenges, and promises of the current and future technological approaches for microbiome profiling and analysis.
越来越明显的是,人类微生物组,也被称为“隐藏的器官”,在维持宿主生理功能的许多过程中具有关键作用,如营养物质提取、生物活性分子的生物合成、与免疫、内分泌和神经系统的相互作用,以及抵抗潜在入侵病原体的定植。在过去的十年中,基于下一代测序的细菌 16s rRNA 基因测序,以及通过第三代测序技术进行全基因组测序的宏基因组方法的发展,是分子生物学的重大进展之一,它可以更好地描绘人类微生物组的组成,从而更深入地了解微生物组在不同疾病发病机制中的重要性。在这种情况下,全面描述与疾病发病机制相关的人类微生物组至关重要,以便通过操纵微生物组来开发新的潜在治疗或预防策略。因此,本观点将重点介绍当前和未来微生物组分析和 profiling 的技术方法的进展、挑战和前景。